Eleva Capital’s Disc Medicine IRON Stock Holding History

Eleva Capital’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-5,115	Closed	-$327K	–	35
2026 Q2	$327K	Hold	5,115	–	–	0.1%	19
2026 Q1	$327K	Buy	+5,115	New	+$355K	0.1%	19

Other funds holding IRON

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Eleva Capital's IRON Position: Q3 2026 in Review

Eleva Capital sold out of Disc Medicine (IRON) in Q3 2026, closing a stake of 5,115 shares — an estimated $327K sold.

Eleva Capital first reported a position in IRON in Q1 2026 and held it in 2 quarters. The position peaked at $327K in Q2 2026. 1 fund tracked by Wall St. Rank holds IRON as of Q3 2026.

Eleva Capital reported no remaining Disc Medicine position as of Q3 2026 after selling out during the quarter.
Eleva Capital sold 5,115 Disc Medicine shares in Q3 2026, an estimated $327K.
Eleva Capital first reported a position in Disc Medicine in Q1 2026 and held it in 2 quarters.
Eleva Capital's Disc Medicine position peaked at $327K in Q2 2026.
1 fund tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on Eleva Capital's 13F filing for Q3 2026, filed 6 Oct 2026.